Follow
Vipul Bhargava
Vipul Bhargava
Senior Principal Scientist, Genentech
Verified email at its.jnj.com
Title
Cited by
Cited by
Year
Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden
ML Stone, KB Chiappinelli, H Li, LM Murphy, ME Travers, MJ Topper, ...
Proceedings of the National Academy of Sciences 114 (51), E10981-E10990, 2017
2422017
Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice
F Veglia, A Hashimoto, H Dweep, E Sanseviero, A De Leo, E Tcyganov, ...
Journal of Experimental Medicine 218 (4), 2021
1512021
Comparative proteogenomics: combining mass spectrometry and comparative genomics to analyze multiple genomes
N Gupta, J Benhamida, V Bhargava, D Goodman, E Kain, I Kerman, ...
Genome research 18 (7), 1133-1142, 2008
1302008
Technical variations in low-input RNA-seq methodologies
V Bhargava, SR Head, P Ordoukhanian, M Mercola, S Subramaniam
Scientific reports 4 (1), 3678, 2014
1092014
Activated plasmacytoid dendritic cells regulate type 2 innate lymphoid cell–mediated airway hyperreactivity
H Maazi, H Banie, GRA Muench, N Patel, B Wang, I Sankaranarayanan, ...
Journal of Allergy and Clinical Immunology 141 (3), 893-905. e6, 2018
772018
A prospective genome-wide study of prostate cancer metastases reveals association of wnt pathway activation and increased cell cycle proliferation with primary resistance to …
L Wang, SM Dehm, DW Hillman, H Sicotte, W Tan, M Gormley, ...
Annals of Oncology 29 (2), 352-360, 2018
742018
Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration‐resistant prostate cancer (CRPC)
SK Pal, J Patel, M He, B Foulk, K Kraft, DA Smirnov, P Twardowski, ...
Cancer 124 (6), 1216-1224, 2018
692018
Quantitative transcriptomics using designed primer-based amplification
V Bhargava, P Ko, E Willems, M Mercola, S Subramaniam
Scientific reports 3 (1), 1740, 2013
552013
Discovery and pharmacological characterization of JNJ-64619178, a novel small-molecule inhibitor of PRMT5 with potent antitumor activity
D Brehmer, L Beke, T Wu, HJ Millar, C Moy, W Sun, G Mannens, V Pande, ...
Molecular cancer therapeutics 20 (12), 2317-2328, 2021
542021
TIM-3 engagement promotes effector memory T cell differentiation of human antigen-specific CD8 T cells by activating mTORC1
NC Sabins, O Chornoguz, K Leander, F Kaplan, R Carter, M Kinder, ...
The Journal of Immunology 199 (12), 4091-4102, 2017
442017
Hybrid simulations of stochastic reaction-diffusion processes for modeling intracellular signaling pathways
KH Chiam, CM Tan, V Bhargava, G Rajagopal
Physical Review E 74 (5), 051910, 2006
422006
Enriched Cd141+ DCs in the joint are transcriptionally distinct, activated, and contribute to joint pathogenesis
M Canavan, AM Walsh, V Bhargava, SM Wade, T McGarry, V Marzaioli, ...
JCI insight 3 (23), 2018
302018
Identification of therapeutic targets for glioblastoma by network analysis
D Friedmann-Morvinski, V Bhargava, S Gupta, IM Verma, S Subramaniam
Oncogene 35 (5), 608-620, 2016
232016
Rheumatoid arthritis synovial microenvironment induces metabolic and functional adaptations in dendritic cells
M Canavan, V Marzaioli, T McGarry, V Bhargava, S Nagpal, DJ Veale, ...
Clinical & Experimental Immunology 202 (2), 226-238, 2020
222020
Restoration of the type I IFN–IL-1 balance through targeted blockade of PTGER4 inhibits autoimmunity in NOD mice
MJ Rahman, KB Rodrigues, JA Quiel, Y Liu, V Bhargava, Y Zhao, ...
JCI insight 3 (3), 2018
92018
Functionally mature cd1c+ dendritic cells preferentially accumulate in the inflammatory arthritis synovium
M Canavan, V Marzaioli, V Bhargava, DJ Veale, U Fearon
Frontiers in Immunology 12, 745226, 2021
82021
Reply to Haffner et al.: DNA hypomethylation renders tumors more immunogenic
ML Stone, KB Chiappinelli, H Li, LM Murphy, ME Travers, MJ Topper, ...
Proceedings of the National Academy of Sciences 115 (37), E8583-E8584, 2018
52018
Molecular profile changes in patients with castrate-resistant prostate cancer pre-and post-abiraterone/prednisone treatment
H Sicotte, KR Kalari, S Qin, SM Dehm, V Bhargava, M Gormley, W Tan, ...
Molecular Cancer Research 20 (12), 1739-1750, 2022
32022
Association of Wnt pathway activation with prechemotherapy abiraterone acetate resistance in metastatic castration-resistant prostate cancer (mCRPC) by genome …
M Kohli, L Wang, S Dehm, DW Hillman, H Sicotte, M Gormley, V Bhargava, ...
Journal of Clinical Oncology 35 (6_suppl), 175-175, 2017
32017
Neoantigen Peptide Mimics
V Krishna, MA Sepulveda, V Bhargava, IS Grewal, K Bachman
US Patent App. 17/556,019, 2022
22022
The system can't perform the operation now. Try again later.
Articles 1–20